Denemek ALTIN - Özgür
Gavi inks agreement with Moderna for COVID-19 vaccine supply to LICs
BioSpectrum Asia
|November 2022
Gavi, the Vaccine Alliance, has signed an agreement with Moderna related to the supply of COVID-19 vaccines to lower-income countries (LICs) supported by the Gavi COVAX Advance Market Commitment (AMC).
-
Under the agreement, Gavi and Moderna agree to cancel remaining volumes under their previous agreement in 2022, and establish a framework for LICs to access doses of variant-containing vaccine (VCV) beginning in 2023. Gavi will have the right to access up to 100 million VCV doses, at Mode
Bu hikaye BioSpectrum Asia dergisinin November 2022 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
BioSpectrum Asia'den DAHA FAZLA HİKAYE
BioSpectrum Asia
Singapore boosts medtech regulatory support and market access
The Health Sciences Authority (HSA) and the Singapore Manufacturing Federation Medical Technology Industry Group (SMF MTIG) are pioneering a comprehensive support ecosystem for Singapore's MedTech industry through their strategic partnership, combining the SME Centre@SMF's services with HSA's Health Products Regulation Group (HPRG) Innovation Office's technical regulatory expertise.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Indian PM approves DSIR Scheme of Capacity Building and HR Development with outlay of Rs 2277 Cr
The Cabinet, chaired by the Prime Minister Narendra Modi, has approved the Department of Scientific and Industrial Research / Council of Scientific and Industrial Research (DSIR/CSIR) Scheme on “Capacity Building and Human Resource (HR) Development” with a total outlay of Rs 2277.397 crore for the period of the Fifteenth Finance Commission Cycle 2021-22 to 2025-26.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Vietnam Rises as a Key Pharmerging Market
Vietnam is emerging as one of Asia's most promising pharmaceutical and biotechnology markets. As the government advances its national pharma strategy and regional collaborations deepen, the country is positioning itself as a future hub for biotech in Southeast Asia. We look at how the key trends are shaping Vietnam's pharma and biotech sectors from regulatory reforms and investment flows to the rise of local innovators.
4 mins
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Australia invests $13.6 M to strengthen its status in world-class clinical trials
The Australian Government is investing $13.6 million to progress key national health and medical research reforms; improve earlier access to emerging treatments, strengthen Australia's clinical trials and deliver better health outcomes for Australians.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
UAE strengthens medical preparedness in emergencies and crises
The Ministry of Health and Prevention (MOHAP), in the United Arab Emirates (UAE), has signed several agreements with many private hospitals from across the UAE to enhance cooperation in areas of preparedness and response to emergencies and reinforce integration between public and private sectors.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Japan develops action plan to use AI in operations
The Pharmaceuticals and Medical Devices Agency (PMDA), Japan's regulatory authority, has developed an Action Plan for the use of AI in Operations.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Starpharma announces collaboration worth $564 M with Genentech for cancer therapies
Starpharma, an Australian biotechnology company, has announced the signing of a collaboration and license agreement with Genentech, a member of the Roche Group, to develop potential cancer therapies that leverage Starpharma's proprietary DEP drug delivery technology.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Boehringer Ingelheim signs $991 M deal with Korea's Aimed Bio for cancer ADC portfolio
Germany's Boehringer Ingelheim and Korean biotech startup AimedBio have announced a global collaboration and licensing agreement to develop a novel antibody-drug conjugate (ADC) therapy for a broad range of cancers.
1 min
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Mind Over Matter: Decoding China's BCI Push
Once popularised by Elon Musk's Neuralink, brain-computer interface (BCI) technology is now drawing major interest in China. We now look at how the country is stepping up research and investment to advance its own BCI ecosystem.
6 mins
BioSpectrum Asia Nov 2025
BioSpectrum Asia
South Korea establishes first comprehensive plan for organ and tissue donation
The Ministry of Health and Welfare (MOHW), South Korea government, has finalised the First Comprehensive Plan for Organ Donation and Transplantation (2026-2030) following a review by the Organ Transplant Ethics Committee.
1 min
BioSpectrum Asia Nov 2025
Translate
Change font size